Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease
- PMID: 2644259
Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease
Abstract
The protease of human immunodeficiency virus has been expressed in Escherichia coli and purified to apparent homogeneity. Immunoreactivity toward anti-protease peptide sera copurified with an activity that cleaved the structural polyprotein gag p55 and the peptide corresponding to the sequence gag 128-135. The enzyme expressed as a nonfusion protein exhibits proteolytic activity with a pH optimum of 5.5 and is inhibited by the aspartic protease inhibitor pepstatin with a Ki of 1.1 microM. Replacement of the conserved residue Asp-25 with an Asn residue eliminates proteolytic activity. Analysis of the minimal peptide substrate size indicates that 7 amino acids are required for efficient peptide cleavage. Size exclusion chromatography is consistent with a dimeric enzyme and circular dichroism spectra of the purified enzyme are consistent with a proposed structure of the protease (Pearl, L.H., and Taylor, W.R. (1987) Nature 329, 351-354). These data support the classification of the human immunodeficiency virus protease as an aspartic protease, likely to be structurally homologous with the well characterized family that includes pepsin and renin.
Similar articles
-
Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.J Biol Chem. 1990 Aug 15;265(23):13890-8. J Biol Chem. 1990. PMID: 2199446
-
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.Proc Natl Acad Sci U S A. 1989 Mar;86(6):1841-5. doi: 10.1073/pnas.86.6.1841. Proc Natl Acad Sci U S A. 1989. PMID: 2648384 Free PMC article.
-
Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.J Gen Virol. 1994 Sep;75 ( Pt 9):2233-9. doi: 10.1099/0022-1317-75-9-2233. J Gen Virol. 1994. PMID: 8077922
-
Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli.J Biol Chem. 1992 Nov 25;267(33):24134-9. J Biol Chem. 1992. PMID: 1331110
-
Expression systems for retroviral proteases.Methods Enzymol. 1994;241:3-16. doi: 10.1016/0076-6879(94)41055-0. Methods Enzymol. 1994. PMID: 7854184 Review. No abstract available.
Cited by
-
The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding.PLoS Pathog. 2016 Jun 9;12(6):e1005657. doi: 10.1371/journal.ppat.1005657. eCollection 2016 Jun. PLoS Pathog. 2016. PMID: 27280284 Free PMC article.
-
Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.Proc Natl Acad Sci U S A. 1990 Jul;87(14):5573-7. doi: 10.1073/pnas.87.14.5573. Proc Natl Acad Sci U S A. 1990. PMID: 2196572 Free PMC article.
-
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.Viruses. 2024 Sep 6;16(9):1423. doi: 10.3390/v16091423. Viruses. 2024. PMID: 39339899 Free PMC article. Review.
-
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6644-8. doi: 10.1073/pnas.87.17.6644. Proc Natl Acad Sci U S A. 1990. PMID: 2204060 Free PMC article.
-
Isolation and characterization of recombinant Drosophila Copia aspartic proteinase.Biochem J. 2006 Nov 1;399(3):535-42. doi: 10.1042/BJ20060800. Biochem J. 2006. PMID: 16813567 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
